Two cancer related bio-pharma stocks in my portfolio are Northwest Biotherapeutics and Cel-Sci.
Interestingly, both are pretty much at the same point now, having concluded very long Phase 3 studies for potential cancer therapies, and are now waiting on data read-outs, which may come any day now.
The Northwest study was for Glioblastoma, and Cel-Sci was for Head and Neck cancer.
Many feel the potential is there for these treatments to be major advances in cancer immunotherapy.
Hopefully some positive results will be forthcoming.
just my opinion